Finance

Lists
AMN:NYSE
AMN Healthcare Services Inc
$34.26
-0.84%
(-0.29) 1D
$34.26
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:12 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMN...
Open
$34.52
High
$34.56
Low
$33.76
Mkt. cap
1.33B
Avg. vol.
661.71K
Volume
1.07M
P/E ratio
12.78
52-wk high
$37.22
52-wk low
$14.97
EPS
$2.68
Beta
0.38
Shares outstanding
38.73M
No. of employees
3K
Open
$34.52
High
$34.56
Low
$33.76
Mkt. cap
1.33B
Avg. vol.
661.71K
Volume
1.07M
P/E ratio
12.78
52-wk high
$37.22
52-wk low
$14.97
EPS
$2.68
Beta
0.38
Shares outstanding
38.73M
No. of employees
3K
News stories
From web sources and news partners
About AMN Healthcare Services Inc
CEOCary Grace
Employees2.66K
Founded1985
Headquarters-
SectorHealth care provider
Websiteamnhealthcare.com
Analyst ratings
Based on 7 analysts giving stock ratings to AMN in the past 3 months
Hold
Buy
2
Hold
4
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AMN in the last 3 months.
Highest
Current $34.26
$40.00 (+16.75%)
Average
$37.00 (+8.00%)
Lowest
$35.00 (+2.16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Silber
BMO Capital
Buy
Maintained
$40.00
+16.8%
09/11/2026
Kevin Fischbeck
Bank of America Securities
Sell
Maintained
-
-
08/07/2026
A.J. Rice
UBS
Hold
Reiterated
$35.00
+2.2%
08/07/2026
Mark Marcon
Robert W. Baird
Hold
Maintained
$36.00
+5.1%
08/07/2026
Bill Sutherland
Benchmark Co.
Hold
Maintained
-
-
08/07/2026
Trevor Romeo
William Blair
Hold
Maintained
-
-
08/07/2026
Tobey Sommer
Truist Financial
Buy
Maintained
-
-
08/04/2026
Joanna Gajuk
Bank of America Securities
Sell
Reiterated
$22.00
-35.8%
05/14/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$24.00
-29.9%
02/23/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.77 / $0.19
+307.77%beat
Revenue / Est. (USD)
673.24M / 628.36M
+7.14%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
634.50M
748.22M
1.38B
673.24M
Cost of goods sold
450.08M
553.10M
1.01B
467.36M
Cost of revenue
450.08M
553.10M
1.01B
467.36M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
138.59M
152.11M
218.42M
147.39M
Operating expense
175.97M
186.97M
251.66M
178.97M
Total operating expenses
626.06M
740.06M
1.26B
646.33M
Operating income
8.44M
8.16M
117.17M
26.91M
Other non operating income
-
-
-
-
EBT including unusual items
37.99M
-4.16M
110.46M
19.90M
EBT excluding unusual items
-1.19M
-4.12M
110.46M
19.90M
Income tax expense
8.70M
3.53M
48.29M
-1.26M
Effective tax rate
22.91%
-84.91%
43.72%
-6.34%
Other operating expenses
-
-
-
-
Net income
29.29M
-7.70M
62.17M
21.16M
Net profit margin
4.62%
-1.03%
4.51%
3.14%
Earnings per share
0.39
0.22
2.10
0.77
Interest and investment income
-
-
-
-
Interest expense
-9.63M
-12.28M
-6.71M
-7.01M
Net interest expenses
-9.63M
-12.28M
-6.71M
-7.01M
Depreciation and amortization charges
37.38M
34.85M
33.24M
31.58M
EBITDA
48.07M
45.39M
152.83M
61.01M
Gain or loss from assets sale
-39.18M
46.00K
3.00K
555.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps